Central nervous system vasculitis in a patient with axial spondyloarthritis treated with infliximab: A case report and literature review

Panagiotis PANAGOPOULOS, Gkikas KATSİFİS

Palmoplantar keratoderma as the preceding cutaneous manifestation of juvenile-onset dermatomyositis

Pratap Kumar PATRA, Aaqib Zaffar BANDAY, Robin BANSAL, Murugan SUDHAKAR, Ankur Kumar JİNDAL

Syringomyelia presenting as neuropathic arthropathy of basal and shoulder joints

Ganesh Singh DHARMSHAKTU

In vitro effect of biological and conventional diseasemodifying antirheumatic drugs on fibrocyte differentiation in patients with rheumatoid arthritis and healthy controls

Helene BROCH TENSTAD, Pernille Just VİNHOLT, Christian NİELSEN, Hanne LİNDEGAARD, Søren Andreas JUST

The association of anti-CD74 antibody with spondyloarthropathies

Tahsin Murat TURGAY, Seda ÇOLAK, Orhan KÜÇÜKŞAHİN, Mustafa Türker DUMAN, Murat TORUNER, Hülya ÇETİNKAYA

What do patients with rheumatoid arthritis know about their own biomedical data related to cardiovascular disease risks?

Tanaka NGCOZANA, Kevin CORBETT, Ajay BHATİA

Ginger extract suppresses the activations of NF-κB and Wnt pathways and protects inflammatory arthritis

Mehmet TUZCU, Cemal ORHAN, Süleyman Serdar KOCA, Burak ÖZ, İbrahim Hanifi ÖZERCAN, Pınar DEMİREL ÖNER, Nurhan ŞAHİN, Vijaya JUTURU, Kazım ŞAHİN

Clinical manifestations of Behçet’s syndrome: A single-center cohort of 777 patients

Demet YALÇIN KEHRİBAR, Metin ÖZGEN, Cemal GÜRBÜZ

Declining in-hospital mortality in vasculitis: A 17-year US national study

Jasvinder SINGH, John CLEVELAND

Biologic treatments in Behçet’s disease

Haner DİRESKENELİ, Fatma ALİBAZ ÖNER

Combination of denosumab and biologic DMARDs in inflammatory muscle-skeletal diseases and connective tissue diseases

Marco MATUCCİ CERİNİC, Cosimo BRUNİ, Cosimo CİGOLİNİ, Giulia TESEİ, Laura COMETİ, Francesca BARTOLİ, Ginevra FİORİ, Francesca NACCİ, Silvia BELLANDO RANDONE, Serena GUİDUCCİ

Use of non-TNF biologics for the treatment of neuro- Behçet’s disease: Literature review and 2 refractory cases of monoclonal anti-TNFs treated with tocilizumab

Yusuf KARABULUT